filgotinib,
GLPG0634,
Filgotinib,
1206161-97-8,
GLPG0634,
GLPG-0634,
Filgotinib (GLPG0634),
UNII-3XVL385Q0M,
N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide,
Filgotinib(GLPG0634),
3XVL385Q0M,
GPLG0634,
SYN1158,
1206101-20-3,
AK171369,
N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide,
N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide,
Filgotinib [USAN:INN],
GLPG 0634,
N-(5-{4-[(1,1-Dioxidothiomorpholin-4-Yl)methyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-Yl)cyclopropanecarboxamide,
Filgotinib (USAN/INN),
Filgotinib; GPLG0634,
SCHEMBL253559,
Filgotinib pound GLPG0643),
GTPL7913,
CHEMBL3301607,
DTXSID80152935,
EX-A741,
BDBM103727,
HMS3653P15,
AOB87315,
BCP08496,
2566AH,
MFCD20527867,
s7605,
ZINC96174616,
AKOS025291103,
CS-2284,
SB16799,
KS-0000063T,
NCGC00345855-01,
NCGC00345855-07,
AS-16295,
BC600462,
HY-18300,
FT-0700114,
FT-0761510,
SW220020-1,
A14232,
D10871,
US8563545, 1,
G146034,
G-146034,
J-690063,
GLPG-0634|||N-[5-[4-[(1,1-Dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide,
Tasocitinib,
Filgotinib [INN],
GLPG0634 analog,
GLPG0634 analogue,
GLPG0634-analogue,
D0SG7B,
C21H23N5O3S,
B1130,
cyclopropanecarboxamide, n-[5-[4-[(1,1-dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-,
Small molecule, JAK1/JAK2 inhibitor (rheumatoid arthritis), Galapagos/GSK,
3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one,